NextBio

Help

Xeroderma pigmentosum (XP) is a human autosomal recessive disease, characterised by a high incidence of sunlight-induced skin cancer. People's skin cells with this condition are hypersensitive to ultraviolet light, due to defects in the incision step of DNA excision repair. There are a minimum of seven genetic complementation groups involved in this pathway: XP-A to XP-G. XP-G is one of the most rare and phenotypically heterogeneous of XP, showing anything from slight to extreme dysfunction in DNA excision repair. XP-G can be corrected by a 133 Kd nuclear protein, XPGC . XPGC is an acidic protein that confers normal UV resistance in expressing cells . It is a magnesium-dependent, single-...

View Biogroup Details



Data Correlations | 1,013 studies

Help for Data Correlations View All

Individual Studies
  • Breast cancer cell lines treated with doxorubicin and p53-RNAi

    score: 100100 | Homo sapiens Homo sapiens | RNA Expression   RNA Expression

    p53-dependent gene expression signatures of four cell lines (MCF-7, ZR-75-1, and two immortalized human mammary epithelial cell lines) were identified by comparing p53-RNAi transduced cell lines to their parent cell lines.

    Organization: University of North Carolina at Chapel H…

View All Individual Studies

Thought leaders and organizations working on research involving XPG I.

  • Kengo Sakaguchi
  • Isabelle Dunand-Sauthier
  • Tomoyuki Furukawa
  • Seisuke Kimura
  • Stuart G Clarkson
  • University Medical Centre
  • Tokyo University of Science
  • University of Texas M.D. Anderson Cancer Center
  • Osaka University
  • Nagoya University

Community

Help for Community
  • No NextBio users were found for “XPG I”.
    Complete your user profile with your interests, if you want others to find you within the NextBio community.

  • No NextBio groups were found for “XPG I”.
    Be the first to start a group and share your interests with others within the NextBio community.